Yoh-Chie Lu

Yoh-Chie Lu General Information

Description

Mr. Yoh-Chie Lu is a Founding Partner of Majuven. Mr. Lu serves as Acting Chief Executive Officer & Chairman at Peregrine Ophthalmic. He serves as Board Member at Moximed. He served as a Venture Partner at Vertex Ventures HC. He serves as Board Member at Innoventures. He is an Angel Investor. Mr. Lu served as Board Member at Nuvaira. He also served as a Board member at Earlens. He founded Biosensors International Group Ltd and served as its chairman and CEO from its inception to 2008. He retained his leadership position as chairman of the Group from January 2008 until November 2016. He has more than 30 years of experience in the medical industry. Prior to starting Biosensors in 1990, he established Asia-based operations for the Medical Division of Gould in Tokyo in 1978. In 1986, he participated in a management-led leveraged buyout of the division from Gould, and he continued as president of the Asia-Pacific division through 1988. He took the company to IPO on Nasdaq, and it was subsequently sold to British Oxygen Corporation. He served as president of Asia-Pacific with British Oxygen until 1990. He is active in both the international and local medical arenas as an entrepreneurial angel investor. He is a General Partner at Foundry Singapore and a venture partner for the medical sector at Vertex Venture Management Pte Ltd. With SPRING, he collaborates with Accuron Technologies Ltd (a wholly-owned subsidiary of Temasek) through the Sector Specific Accelerator program. He serves on the board of directors for Visterra and Innoventures. He also served as a Board Member at Ivantis. In 1990, he also founded Sun Instruments Japan, Suncscope International in California, and Biosensors International in Singapore, all of which are now subsidiaries of Biosensors International Group Ltd.